The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA

Human Gene Therapy

Volumn 16, Issue 4, 2005, Pages 533-539

  Jenke, Andreas C W ^a   Eisenberger, Tobias ^b   Baiker, Armin ^b   Stehle, Isa M ^b   Wirth, Stefan ^a   Lipps, Hans Joachim ^b  

^a HELIOS KLINIKUM WUPPERTAL   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; INTERLEUKIN 3; MESSENGER RNA; PROTEIN; PROTEIN PEPI 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; GENE REPLICATION; GENE REPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; NORTHERN BLOTTING; RNA INTERFERENCE; SOUTHERN BLOTTING; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL PROLIFERATION; CYTOKINES; DNA POLYMERASE III; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; PLASMIDS; PROMOTER REGIONS (GENETICS); RNA; RNA, CATALYTIC; VIRUS REPLICATION;

MAMMALIA;

EID: 18444376514     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.533     Document Type: Article

References (28)

1. BAIKER, A., MAERCKER, C., PIECHACZEK, C., SCHMIDT, S.B., BODE, J., BENHAM, C., and LIPPS, H.J. (2000). Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix. Nat. Cell Biol. 2, 182-184.
2. BARTEL, D.P. (2004), MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
3. CAPLEN, N.J., PARRISH, S., IMANI, F., FIRE, A., and MORGAN, P.A. (2001). Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. U.S.A. 98, 9742-9747.
4. DALEY, G.Q., VAN ETTEN, R.A., and BALTIMORE, D. (1990). Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824-830.
5. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
6. FIRE, A. (1999). RNA-triggered gene silencing. Trends Genet. 15, 358-363.
7. HANNON, G.J. (2002). RNA interference. Nature 418, 244-251.
8. HUETTNER, C.S., ZHANG, P., VAN ETTEN, R.A., and TENEN, D.G. (2000). Reversibility of acute B-cell leukemia induced by BCR ABL1. Nat. Genet. 24, 57-60.
9. JENKE, A.C., SCINTEIE, M.F., STEHLE, I.M., and LIPPS, H.J. (2004a). Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation. Mol. Biol. Rep. 31, 85-90.
10. JENKE, A.C., STEHLE, I.M., HERRMANN, F., EISENBERGER, T., BAIKER, A., BODE, J., FACKELMAYER, F.O., and LIPPS, H.J. (2004b). Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. Proc. Natl. Acad. Sci. U.S.A. 101, 11322-11327.
11. KIM, D.H., LONGO, M., HAN, Y., LUNDBERG, P., CANTIN, E., and ROSSI, J.J. (2004). Interferon induction by siRNAs syntethized by phage polymerase. Nat. Biotechnol. 22, 321-325.
12. LEE, N.S., DOHIJMA, T., BAUER, G., LI, H., LI, M.J., EHSANI, A., SALVATERRA, P., and ROSSI, J. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500-505.
13. LIPPS, H.J., JENKE, A.C., NEHLSEN, K., SCINTEIE, M.F., STEHLE, I.M., and BODE, J. (2003). Chromosome-based vectors for gene therapy. Gene 30, 23-33.
14. LUGO, T., PENDERGAST, A.M., MULLER, A.J., and WITTE, O.N. (1990). Tyrosine kinase activity and transformation potency of byr-abl oncongen products. Science 247, 1019-1082.
15. MAURO, M.J., and DRUKER, B.J. (2001). STI571: Targeting BCR-ABL as therapy for CML. Oncologist 6, 233-238.
16. MCCAFFREY, A.P., NAKAI, H., PANDEY, K., HUANG, Z., SALAZAR, F.H., XU, H., WIELAND, S.F., MARION, P.L., and KAY, M.A. (2003). Inhibition of hepatits B virus in mice by RNA interference. Nat. Biotechnol. 21, 639-644.
17. NAKAI, H., MONTINI, E., FUESS, S., STORM, T.A., GROMPE, M., and KAY, M.A. (2003). AAV serotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34, 297-302.
18. PADDISON, P.J., CAUDY, A.A., BERNSTEIN, E., HANNON, G.J., and CONKLIN, D.S. (2002). Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 853-858.
19. PEGGS, K., and MACKINNON, S. (2003). Imatinib mesylate - The new gold standard for treatment of chronic myeloid leukemia. N. Engl. J. Med. 348, 1048-1050.
20. PIECHACZEK, C., FETZER, C., BAIKER, A., BODE, J., and LIPPS, H.J. (1999). A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res. 27, 426-428.
21. SCHAARSCHMIDT, D., BALTIN, J., STEHLE, I.M., LIPPS, H.J., and KNIPPERS, R. (2004). An episomal mammalian replicon: Sequence-independent binding of the origin recognition complex. EMBO J. 23,191-201.
22. SCHERER, L.J., and ROSSI, J.J. (2003). Approaches for the sequence-specific knockdown of mRNA. Blood 21, 1457-1465.
23. SCHERR, M., BATTMER, K., WINKLER, T., HEIDENREICH, O., GANSER, A., and EDER, M. (2003). Specific inhibition of bcr-abl expression by small interfering RNA. Blood 101, 1566-1569.
24. SIJEN, T., FLEENOR, J., SIMMER, F., THIJSSEN, K.L., PARRISH, S., TIMMONS, L., PLASTERK, R.H., and FIRE, A. (2001). On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107, 465-476.
25. STEHLE, I.M., SCINTEIE, M.F., BAIKER, A., JENKE, A.C., and LIPPS, H.J. (2003). Exploiting a minimal system to study the epigenetic control of DNA replication: The interplay between transcription and replication. Chromosome Res. 11, 413-421.
26. SUI, G., SOOHOO, C., AFFAR, E.L.B., GAY, F., SHI, Y., FORRESTER, W.C., and SHI, Y. (2002). A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 1443-1448.
27. TAVERNARAKIS, N., WANG, S.L., DOROVKOV, M., RYAZANOV, A., and DRISCOLL, M. (2000). Heritable and inducible genetic interference by double-stranded RNA encoded transgenes. Nat. Genet. 24, 180-183.
28. ZHANG, Y.C., POWERS, M., WASSERFALL, C., BRUSKO, T., SONG, S., FLOTTE, T., SNYDER, R.O., POTTER, M., SCOTT-JORGENSEN, M., CAMPBELL-THOMPSON, M., CRAWFORD, J.M., NICK, H.S., AGARWAL, A., ELLIS, T.M., and ATKINSON, M.A. (2004). Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Ther. 11, 233-240.